Augmentin Treatment Duration Guidelines

Introduction to Treatment Duration

The American College of Physicians and other medical societies support the use of Augmentin for 5-10 days depending on the specific infection type and severity, with respiratory tract infections typically requiring 5-7 days and streptococcal infections requiring a full 10 days 1

For uncomplicated community-acquired pneumonia and acute bacterial rhinosinusitis, 5-7 days of Augmentin treatment is adequate for adults with mild-to-moderate infections who are afebrile for 48 hours and clinically stable 2, 1
The Infectious Diseases Society of America recommends a shortened duration of 5-7 days based on multiple randomized controlled trials showing equivalent efficacy to longer courses 2
For children with acute bacterial rhinosinusitis, treatment with Augmentin for 5-8 days is recommended 3
For severe pneumonia, a minimum of 7 days of Augmentin treatment is recommended, and treatment should continue until the patient has been afebrile for 48-72 hours and reaches clinical stability 2

For uncomplicated urinary tract infections, 3-7 days of Augmentin treatment is sufficient 6

For melioidosis, the intensive phase of treatment with Augmentin should last for a minimum of 14 days, followed by an eradication phase of 3-6 months 2
For methicillin-resistant Staphylococcus aureus (MRSA) infections, longer treatment courses are recommended, although Augmentin is not the first-line treatment 2

For group A streptococcal pharyngitis, treatment with Augmentin should always be for a full 10 days, regardless of clinical improvement, to prevent acute rheumatic fever 1

For children under 2 years with acute otitis media, 10-day treatment courses with Augmentin are recommended due to a higher risk of treatment failure 3
For pediatric patients with acute bacterial rhinosinusitis, treatment with Augmentin for 10-14 days or until symptom-free for 7 days is recommended 3, 6

The Infectious Diseases Society of America recommends continuing treatment for at least 48-72 hours beyond when the patient becomes asymptomatic or evidence of bacterial eradication is obtained, although this is not explicitly cited in the provided text, similar recommendations are made by 2

Never stop streptococcal treatment early, even if symptoms resolve quickly, to prevent acute rheumatic fever 1
Avoid underdosing in areas with high penicillin-resistant S. pneumoniae prevalence (>10%) and use high-dose formulations (875 mg/125 mg twice daily for adults or 90 mg/kg/day for children) 6
Reassess patients at 48-72 hours, and if there is no clinical improvement, consider treatment failure and alternative management 3, 6